Top Stories of the Day India: NMC Issues Warning for Medical Colleges Regarding Faculty Attendance WHO Classifies SARS-CoV-2 Variant JN.1 as a Variant of Interest USFDA Approves the First Topical Gel for Epidermolysis Bullosa The UK Approves Fezolinetant for Treating Vasomotor Symptoms